<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-99201</identifier>
<setSpec>0211-6995</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">No disponible</dc:title>
<dc:description xml:lang="en">&#149; Metabolic syndrome (MS) encompasses a series of diseases which, when combined, increase vascular risk more than the sum of their individual risks. Insulin resistance (IR) is one of the basic components of MS.&#149; Abdominal fat distribution is an IR marker and is associated to factors increasing vascular risk such as dyslipidemia, highblood pressure, and hyperglycemia, components of the so-called metabolic syndrome.&#149; IR is related to glomerular sclerosis and renal failure through several mechanisms, Including genetic and environmental factors,and stimulation of the renin-angiotens in-aldosterone system.&#149; IR usually precedes development of DM, and therefore contributes to its early identification. MS increases the risk of chronic complications from DM and is associated to an increased prevalence of cardiovascular disease, particularly coronary heart disease, increasing mortality from this cause.&#149; The presence of MS in DM2 is usually associated to a greater prevalence of microalbuminuria or proteinuria and peripheral polyneuropathy (AU)</dc:description>
<dc:creator>Martínez Castelao, A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">&#149; El Síndrome Metabólico (SM) resume la existencia de toda una serie de enfermedades que, sumadas, incrementan el riesgo vascular más que la adición de sus riesgos individuales. La resistencia a la Insulina (RI) es uno de los componentes básicos del SM.&#149; La distribución de la grasa abdominal es un marcador de RI y se asocia a factores que incrementan el riesgo vascular: dislipemia, hipertensión arterial, HTA, hiperglucemia, componentes del llamado Síndrome Metabólico.&#149; La RI está ligada a la producción de esclerosis glomerulare insuficiencia renal, a través de diversos mecanismos: genéticos, factores ambientales y estimulación del Sistema Renina-Angiotensina-Aldosterona.&#149; La RI suele preceder al desarrollo de la DM, con lo que contribuye a la identificación precoz de la misma. El SM incrementa el riesgo de complicaciones crónicas de la DM y se asocia con una mayor prevalencia de enfermedad cardiovascular, sobre todo de enfermedad coronaria, incrementando la mortalidad por esta causa.&#149; La presencia de SM en la DM-2 suele acompañarse de mayor prevalencia de microalbuminuria o proteinuria y de polineuropatía periférica (AU)</dc:description>
<dc:source>Nefrologia;28(supl.3): 33-37, ene.-dic. 2008. ilus, tab</dc:source>
<dc:identifier>ibc-99201</dc:identifier>
<dc:title xml:lang="es">Síndrome metabólico y nefropatía</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d29407^s22045</dc:subject>
<dc:subject>^d2359^s22080</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d50497^s22012</dc:subject>
<dc:subject>^d422^s22080</dc:subject>
<dc:subject>^d36032^s22012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d3946^s22080</dc:subject>
<dc:subject>^d11946^s22080</dc:subject>
<dc:type>article</dc:type>
<dc:date>200812</dc:date>
</metadata>
</record>
</ibecs-document>
